Product Program year 2025 Source: CMS Open Payments

Neffy

Drug Allergy

NDC 82580-020-02

Open in the dashboard

General payments

$2,097,895

23,693 payments

Research payments

$144,169

24 payments

Through program year 2025, $2,097,895 in general payments and $144,169 in research payments were reported against Neffy (Allergy).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

2 rows
Year Kind Amount Payments
2025 General $2,097,895 23,693
2025 Research $144,169 24

Breakdown

Who paid General payments · program year 2025
  1. ARS Pharmaceuticals Operations, Inc. $2,097,895 23,693 payments
Top recipients General payments · program year 2025
  1. Matthew Greenhawt Pediatric Allergy/Immunology · Aurora, CO $153,584 7% · 122 payments
  2. David Golden Allergy · Baltimore, MD $100,713 5% · 67 payments
  3. Raffi Tachdjian Allergy & Immunology · Santa Monica, CA $85,337 4% · 63 payments
  4. Maeve Oconnor Allergy & Immunology · Charlotte, NC $71,104 3% · 52 payments
  5. Vandana Patel Allergy & Immunology · Charlotte, NC $69,412 3% · 88 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Allergy & Immunology $1,125,760 54% · 1,394 practitioners
  2. Allergy Allergy & Immunology $290,221 14% · 307 practitioners
  3. Pediatric Allergy/Immunology Pediatrics $200,406 10% · 93 practitioners
  4. Pediatrics $111,044 5% · 2,322 practitioners
  5. Nurse Practitioner, Family Nurse Practitioner $68,183 3% · 1,122 practitioners

The top 5 of 123 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. California $223,961 11% · 803 recipients
  2. North Carolina $221,557 11% · 445 recipients
  3. Colorado $176,196 8% · 78 recipients
  4. Illinois $167,654 8% · 363 recipients
  5. New York $163,456 8% · 916 recipients

The top 5 of 52 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

23,693 general · 24 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record